OTC “Convenience-Size” Two-Dose Rule Should Allow For Exemptions – CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA should extend its classification of "convenience-size" OTCs beyond the two-dose limit outlined in a recent rule partially delaying "Drug Facts" labeling compliance for such products, the Consumer Healthcare Products Association says